# Design of Quinoline-Derived Schiff Base Metal Complexes as Bioactive Drug Candidates: Structural Elucidation, Stability Determination, DFT, and Docking Studies with DNA-Targeting Potential Profiles

## TL;DR

This paper reports the design and testing of new quinoline-based metal complexes with potential as antimicrobial and anticancer drugs.

## Contribution

The study introduces novel metal complexes with enhanced bioactivity and validates their DNA-targeting potential through experimental and computational methods.

## Key findings

- The Pd(II) complex showed superior antimicrobial activity compared to standard drugs.
- The Pd(II) complex exhibited strong anticancer activity against Hep-G2, MCF-7, and HCT-116 cell lines.
- Molecular docking confirmed favorable interactions with microbial proteins and cancer-related targets.

## Abstract

Three novel metal complexes of the tridentate ligand 4-nitro-2-(quinolin-8-yliminomethyl)phenol (NQP) were synthesized and fully characterized using elemental analysis, TGA, magnetic susceptibility, FT-IR, NMR, and UV–Vis spectroscopy. Stoichiometric studies and characterization data proposed square-planar Pd(II), tetrahedral Zn(II), and octahedral Fe(III) geometries. Density functional theory calculations (B3LYP and B3LYP/6-311G(d,p) with LANL2DZ for metals) showed good agreement with experimental findings and revealed enhanced nonlinear optical properties, as evidenced by increased polarizability and hyperpolarizability values. Biological studies demonstrated significant antimicrobial activity, with the Pd–NQP complex exhibiting superior efficacy against bacterial and fungal strains compared to ofloxacin and fluconazole, following the order NQP < Zn < Fe < Pd. Cytotoxicity assays against Hep-G2, MCF-7, and HCT-116 cell lines revealed strong anticancer activity, particularly for the Pd(II) complex (IC50 = 6.35–12.95 μg/μL), comparable to cisplatin. All complexes showed higher DPPH radical scavenging activity than ascorbic acid and strong DNA-binding affinity. Antimicrobial activity was further validated experimentally, while molecular docking studies elucidated favorable binding interactions with microbial proteins and cancer-related targets.